PROLENSA (bromfenac ophthalmic solution) 0.07% > Home
WEBPROLENSA (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated to treat inflammation and reduce eye pain in patients after cataract surgery. PROLENSA® contains sodium sulfite, a substance that may cause allergic reactions, some severe, in certain people.
Save on PROLENSA
WEBThe PROLENSA Part D Program offers savings for Medicare Part D patients. Most eligible patients pay as little as an $80 copay on their PROLENSA ® prescription. †
DELIVER THE PROLENSA
WEBPROLENSA ® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
EMPOWER YOUR PRACTICE WITH - why-prolensa?
WEBPROLENSA ® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
About PROLENSA
WEBTreatment of inflammation and pain after cataract surgery. PROLENSA ® reduced inflammation in eyes as early as 8 days after cataract surgery. About 4 out of 5 patients taking PROLENSA ® were pain-free the day after surgery with one dose given the day of surgery*. *Individual results may vary.
POWERED FOR PATIENT SAVINGS - prolensarx.com
WEBThe PROLENSA Part D Program offers savings for Medicare Part D patients. Most eligible patients pay as little as an $80 copay on their PROLENSA ® prescription. †
FAQs - prolensarx.com
WEBPROLENSA ® is a nonsteroidal anti-inflammatory drug (NSAID) taken as an eye drop. Your doctor will have you take PROLENSA ® one day before surgery, on the day of your surgery, and once daily through the treatment period. If you have further questions about PROLENSA ®, talk to your eye doctor.
WEBPROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated to treat inflammation and reduce eye pain in patients after cataract surgery. IMPORTANT SAFETY INFORMATION
WEB• PROLENSA (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-infl ammatory drug (NSAID) indicated for the treatment of postoperative infl ammation and reduction of ocular pain in patients who have undergone cataract surgery.
ADDITIONAL RESOURCES - prolensarx.com
WEBPROLENSA ® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.